Origin Therapeutics Holdings, Inc. (TSE:SPLY) has released an update.
Safe Supply is set to acquire Drug Lab 118 Ltd.’s subsidiary, enhancing its medical testing portfolio with proprietary harm reduction test strips for the North American market. The deal involves the issuance of 10 million Safe Supply shares and the addition of a Drug Lab Parent nominee to Safe Supply’s board. This strategic move aims to capitalize on the growing market for narcotic testing and harm reduction solutions.
For further insights into TSE:SPLY stock, check out TipRanks’ Stock Analysis page.
